Record updated: April 16, 2021, 10:59 a.m. by The FAIRsharing Team.

Edits to 'https://fairsharing.org/FAIRsharing.xvsv9z' by 'The FAIRsharing Team' at 10:59, 16 Apr 2021 (approved):

	'organizations' has been modified:
		Before:
			National Institutes of Health (NIH), Bethesda, MD, USA|https://www.nih.gov/|Maintains
			National Human Genome Research Institute (NHGRI), Bethesda, MD, USA|http://www.genome.gov/|Funds
		After:
			National Human Genome Research Institute (NHGRI), Bethesda, MD, USA|http://www.genome.gov/|Funds
			National Institutes of Health (NIH), Bethesda, MD, USA|https://www.nih.gov/|Funds
		Added:
			National Institutes of Health (NIH), Bethesda, MD, USA|https://www.nih.gov/|Funds
		Removed:
			National Institutes of Health (NIH), Bethesda, MD, USA|https://www.nih.gov/|Maintains

	'miriam_id' has been modified:
		Before: None
		After: 

            

Edits to 'https://fairsharing.org/FAIRsharing.xvsv9z' by 'The FAIRsharing Team' at 05:21, 28 Nov 2016 (approved):

	'description' has been modified:
		Before: Human biospecimens are subject to a number of different collection, processing, and storage factors that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research utilizing human tissues, it is critical that information regarding the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications around biospecimen-related research and help reassure patient contributors and the advocacy community that the contributions are valued and respected
		After: The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined are intended to apply to any study in which human biospecimens are used. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications around biospecimen-related research and help reassure patient contributors and the advocacy community that the contributions are valued and respected. Publication List has changed:  Previous values: Biospecimen reporting for improved study quality (BRISQ). New values:  Biospecimen reporting for improved study quality (BRISQ)